[{"Assets_0_Q3_USD":178707000.0,"CommonStockSharesOutstanding_0_Q3_shares":111035248.0,"EarningsPerShareBasic_1_Q3_USD":0.16,"EarningsPerShareBasic_3_Q3_USD":0.28,"EarningsPerShareDiluted_1_Q3_USD":0.15,"EarningsPerShareDiluted_3_Q3_USD":0.26,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":42074000.0,"NetIncomeLoss_1_Q3_USD":17457000.0,"NetIncomeLoss_3_Q3_USD":29853000.0,"StockholdersEquity_0_Q3_USD":142472000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":117501925.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":116547006.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":106871436.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":106469278.0,"Ticker":"MDXG","CIK":"1376339","name":"MIMEDX GROUP, INC.","OfficialName":"MiMedx Group Inc Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"515730569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171031"}]